ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Research Reveals Global Predictors of Heart Attack Mortality, Offering Tools to Save Millions of Lives and Billions in Healthcare Costs

New Research Reveals Global Predictors of Heart Attack Mortality, Offering Tools to Save Millions of Lives and Billions in Healthcare Costs

Heart disease continues to claim more lives than any other condition globally, with acute myocardial infarction (AMI) — commonly known as a heart attack — accounting for more than 9 million deaths each year. Despite advancements in cardiovascular care, gaps in understanding who is most at risk remain a significant obstacle to reducing mortality and improving outcomes. A landmark study published in Cureus delivers powerful new insights into the predictors of death among hospitalized heart attack patients, using data drawn from over one million admissions across the United States.

The study, titled "Predictors of Mortality in Acute Myocardial Infarction: Insights From the Healthcare Cost and Utilization Project (HCUP) Nationwide Readmission Database," was authored by Priji Prasad Jalaja, Dheeraj Kommineni, Aashish Mishra, Ramakrishna Tumati, Chrishanti Anna Joseph, and Rana Veer Samara Sihman Bharattej Rupavath. Leveraging the extensive 2020 HCUP Nationwide Readmission Database (NRD), the researchers analyzed 1,193,046 AMI-related hospitalizations, identifying critical risk factors for 30-day mortality — including cardiac arrest, cardiogenic shock, acute kidney injury, extreme severity at admission, and COVID-19 co-infection.

“This is a timely and high-impact study that cuts through clinical complexity to offer a clear picture of who is most vulnerable,” said Lukas Meier, Senior Journalist at Alpine Vision Media. “What’s remarkable is how it moves beyond abstract theory by using real-world hospital data to provide targeted, actionable predictors of death following a heart attack.” The analysis found that 127,128 patients —10.7% of the cohort — died within 30 days of admission. Older age, male gender, and COVID-19 infection were significant contributors to increased risk, while institutional factors like self-pay status and treatment at micropolitan hospitals also elevated mortality odds.

“These findings could help health systems worldwide identify high-risk patients earlier and allocate resources more efficiently,” Meier explained. “By implementing data-driven risk stratification tools, we could save over a million lives in the next decade and prevent tens of billions of dollars in healthcare costs related to emergency interventions, complications, and readmissions.”

Beyond individual risk factors, the study exposes stark institutional and socioeconomic disparities that impact survival. Patients without insurance were 24% more likely to die, and those treated at smaller, rural hospitals faced up to 72% higher risk.“This underscores a global truth: where you live and how much you can pay still determine your chances of survival,” Meier stated. “Studies like this provide governments and policymakers with the evidence base they need to close these life-threatening gaps.”

The research has attracted attention from leading cardiovascular experts in emerging regions. Dr. Mpho Sebogodi of Chris Hani Baragwanath Hospital in South Africa emphasized the relevance of the study for developing countries with overstretched public health systems. Similarly, Dr. Valéria Monteiro of São Paulo’s Hospital do Coração in Brazil and Dr. Tarek El-Masry of Alexandria University Hospitals in Egypt commended the study for its potential to inform resource allocation and patient triage protocols in settings where cardiac care infrastructure remains limited.

“What distinguishes this publication is its ability to resonate globally,” Meier added. “From South America to Africa and the Middle East, the study’s implications are profound: identify, intervene, and equalize access — before it’s too late.” Looking ahead, the authors recommend integrating race, education, and vaccination status into future risk models and call for further research to develop predictive frameworks that are adaptable across healthcare systems. “In the era of precision medicine, we must move beyond one-size-fits-all models,” Meier concluded. “This study marks a pivotal step toward patient-specific, data-guided interventions that can truly transform outcomes for millions worldwide.”

Reference: Prasad Jalaja P, Kommineni D, Mishra A, et al. (May 07, 2025) Predictors of Mortality in Acute Myocardial Infarction: Insights From the Healthcare Cost and Utilization Project (HCUP) Nationwide Readmission Database. Cureus 17(5): e83675. DOI 10.7759/cureus.83675

Media Contact
Company Name: Alpine Vision Media
Contact Person: Lukas Meier
Email: Send Email
Country: Switzerland
Website: https://alpinevisionmedia.com/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.